Edesa Biotech
高管
查看带有其 11 名主要高管的组织结构图
Edesa Biotech 搜索最多的简介
- Par Nijhawan, Chief Executive Officer and Director
- Patrick Marshall, Director
- Frank Oakes, Board Director
创建提醒
跟踪 Edesa Biotech 的高管变动
生物技术
Edesa Biotech 拥有 2,346 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Genus (联合王国)。
Popular M&A news in 生物技术
- Tempero Bio 刚刚宣布为 70 筹款数百万美元。 (公布2025三月25号).
- 23andMe has filed for bankruptcy protection 23andMe (公布2025三月25号).
- Latigo Biotherapeutics 刚刚宣布为 150 筹款数百万美元。 (公布2025三月24号).
生物技术 行业的其他推荐联系人
消息
Edesa Biotech 的最新新闻稿
- Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
- Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- Edesa Biotech Reports Fiscal Year 2024 Results
- Edesa Biotech’s Founder Makes Strategic Investment in the Company
- Edesa Biotech Announces Upcoming Conference Schedule
- News Archive 2023 | Edesa Biotech, Inc. (Nasdaq: EDSA)
- News Archive 2020-2019 | Edesa Biotech, Inc. (Nasdaq: EDSA)
- News Archive 2022 | Edesa Biotech, Inc. (Nasdaq: EDSA)
- News Archive 2021 | Edesa Biotech, Inc. (Nasdaq: EDSA)
- Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results
- View more press releases Close
